Characterization of Factor VIII B-Cell Inhibitory Epitopes
- 1 January 1999
- journal article
- research article
- Published by Georg Thieme Verlag KG in Thrombosis and Haemostasis
- Vol. 82 (08) , 505-508
- https://doi.org/10.1055/s-0037-1615872
Abstract
Factor VIII contains three epitopes that are the usual targets of clinically significant antibody inhibitors. Two of these epitopes are located in the A2 and C2 domains of factor VIII. The third epitope appears to be in the A3 domain. Ongoing studies continue to provide higher resolution maps of these epitopes and to understand the mechanism by which inhibitors produce a bleeding diathesis. The manipulation of inhibitor epitopes using recombinant DNA technology may lead to improved forms of factor VIII that have lower antigenicity and/or lower immunogenicity.Keywords
This publication has 17 references indexed in Scilit:
- Cross‐reactivity to porcine factor VIII of factor VIII inhibitors in patients with haemophilia in Australia and New ZealandAustralian and New Zealand Journal of Medicine, 1997
- Analysis of the Human Factor VIII A2 Inhibitor Epitope by Alanine Scanning MutagenesisPublished by Elsevier ,1997
- Residues 484-508 Contain a Major Determinant of the Inhibitory Epitope in the A2 Domain of Human Factor VIIIJournal of Biological Chemistry, 1995
- Inhibition of human factor VIIIa by anti-A2 subunit antibodies.Journal of Clinical Investigation, 1994
- Recombinant Factor VIII for the Treatment of Previously Untreated Patients with Hemophilia A -- Safety, Efficacy, and Development of InhibitorsNew England Journal of Medicine, 1993
- High resolution functional analysis of antibody-antigen interactionsJournal of Molecular Biology, 1992
- Epitopes on protein antigens: Misconceptions and realitiesCell, 1990
- Epitope mapping of human factor VIII inhibitor antibodies by deletion analysis of factor VIII fragments expressed in Escherichia coli.Proceedings of the National Academy of Sciences, 1988
- Localization of human factor FVIII inhibitor epitopes to two polypeptide fragments.Proceedings of the National Academy of Sciences, 1985
- A More Uniform Measurement of Factor VIII InhibitorsThrombosis and Haemostasis, 1975